ovarian%20mass
OVARIAN MASS
Ovarian cysts are typically noted after clinical screening, or as a result of exam for a suspected pelvic mass, or an incidental finding in investigations done for other reasons.
Most ovarian masses manifest with few or mild nonspecific symptoms.
Ovarian masses in women of reproductive age are mostly benign but the risk of malignancy increases with age.
Ovarian cysts in the prepubertal patients especially after the first week of life are abnormal and likely to be neoplastic. In adolescent patients, majority of ovarian masses are functional cysts.

Pharmacotherapy

Monophasic Combination Oral Contraceptives (COCs)

  • Studies suggested that expectant management is as effective as hormonal treatment for the resolution of functional ovarian cysts
  • Patients may be offered oral contraceptives (OCs) if they are seeking contraception
  • Estrogen/progestogen therapy may be useful in patients with anovulatory cycles who need OCs to induce the next period
  • Many monophasic combination oral contraceptives are available. Please see the latest MIMS for specific formulations
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
No association exists between physical activity and the risk of urological cancer, according to a population-based prospective study in Japan.
5 days ago
Patients with childhood-onset inflammatory bowel disease are more likely to die than the general population, a study suggests.
5 days ago
Reduced caloric intake results in a significant improvement in glucose metabolism and body-fat composition, including liver-fat content, according to a study. Changes in ferritin levels appear to mediate the striking reduction in liver fat.
Pearl Toh, 5 days ago
A latest study at ISC 2019 shows that even patients with large-core stroke damage can have a good outcome after mechanical clot removal with endovascular thrombectomy (EVT), depending on the size of the infarct and time lapses between stroke onset and treatment.